| PERIOD ENDING | 12-Apr-09 | 18-Jan-09 | 28-Sep-08 | 6-Jul-08 | | Total Revenue | 1,857,550 | 2,466,503 | 1,788,919 | 1,841,242 | | Cost of Revenue | 1,212,233 | 1,643,785 | 1,192,917 | 1,208,495 | | | Gross Profit | 645,317 | 822,718 | 596,002 | 632,747 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 557,224 | 736,574 | 531,143 | 550,877 | | Non Recurring | 18,440 | 19,141 | 42,310 | 17,781 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 69,653 | 67,003 | 22,549 | 64,089 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (639) | 1,841 | 1,267 | 1,495 | | Earnings Before Interest And Taxes | 69,014 | 68,844 | 23,816 | 65,584 | | Interest Expense | 7,696 | 13,580 | 8,303 | 8,094 | | Income Before Tax | 61,318 | 55,264 | 15,513 | 57,490 | | Income Tax Expense | 26,060 | 22,935 | 14,011 | 23,571 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 35,258 | 32,329 | 1,502 | 33,919 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 35,258 | 32,329 | 1,502 | 33,919 | | Preferred Stock And Other Adjustments | (7,934) | (4,533) |
-
|
-
| | | Net Income Applicable To Common Shares | $27,324 | $27,796 | $1,502 | $33,919 |
|
0.45% Nasdaq 
0.20%
Income Statement
